United Atlantic Ventures, LLC v. Odyssey Transfer and Trust Company

CourtDistrict Court, D. Delaware
DecidedSeptember 6, 2024
Docket1:24-cv-00838
StatusUnknown

This text of United Atlantic Ventures, LLC v. Odyssey Transfer and Trust Company (United Atlantic Ventures, LLC v. Odyssey Transfer and Trust Company) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United Atlantic Ventures, LLC v. Odyssey Transfer and Trust Company, (D. Del. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE UNITED ATLANTIC VENTURES, LLC, Plaintiff,

v. Civil Action No. 24-838-GBW ODYSSEY TRANSFER AND TRUST COMPANY, Defendant,

MEMORANDUM OPINION Pending before the Court is United Atlantic Ventures, LLC’s (“UAV”) Motion for Summary Judgment (D.I. 16) and Odyssey Transfer and Trust Co.’s (“Odyssey”) Cross-Motion for Summary Judgment (D.I. 21). The parties have stipulated that there are no factual disputes and that this case can be resolved on summary judgment. See D.I. 9. After hearing oral argument (“Tr.”) and for the reasons that follow, the Court GRANTS UAV’s Motion for Summary Judgment and DENIES Odyssey’s Cross-Motion for Summary Judgment.

1. BACKGROUND UAV is a minority shareholder in Trump Media and Technology Group (“TMTG”). Odyssey is the transfer agent for TMTG. TMTG has gone public through a merger process with a special purpose acquisition company. UAV and TMTG have been embroiled in litigation, and UAV received an order from the Delaware Chancery Court compelling TMTG to give UAV an 8.6% equity interest in TMTG and “otherwise cooperate with [UAV] and [TMTG]’s transfer agent [Odyssey] to ensure that [UAV] receives all [TMTG] stock and earn-out stock to which it is

entitled concurrent with the delivery of any stock to Donald J. Trump,!' Bradford Cohen and/or the TMTG Noteholders.” D.I. 1, Ex. F §§ 3-4. UAV’s shares of TMTG, like those of Trump and Cohen, contain a lockup, publicly disclosed in SEC filings and set to expire on the earliest of

(i) the date that is six months after the closing date of the [Merger], (11) the date on which the closing price for the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalization and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the closing date of the [Merger], and (iii) the date after the closing of the [Merger] on which the Corporation consummates a liquidation, merger, share exchange or other similar transaction that results in all of the Corporation’s stockholders having the right to exchange their equity holdings in the Corporation for cash, securities or other property. The Second Amended Charter, EDGAR, Securities and Exchange Commission (2024), https://www.sec.gov/Archives/edgar/data/1849635/0001 1403612401671 9/ef2002 5342_ex3-2.htm. (the “Second Amend. Charter”). The lockup will expire on September 19, 2024, if TMTG shares trade over $12.00 per share until that date.”

UAV fears that Odyssey will refuse to transfer UAV’s shares concurrently with Trump’s. UAV reached out to Odyssey to confirm that Odyssey would remove transfer restrictions from UAV’s shares on September 19, 2024, if the share price continues to exceed $12. On May 15, 2024, UAV sent a letter to Odyssey inquiring as to whether Odyssey received instructions from TMTG regarding the expiration of the lockup. D.I. 1, Ex. H. On May 22, 2024, Odyssey replied that it would “be taking direction from TMTG and its legal counsel.” D.I. 1, Ex. I; see D.I. 1, Ex. J (Odyssey indicating on June 12 that it will “take direction from the issuer”). UAV reached out to TMTG to confirm that it will instruct Odyssey to remove any and all transfer restrictions and deliver UAV its shares

' The controlling shareholder of TMTG. * The shares of TMTG currently trade at around $17.50.

concurrently with any delivery to Trump. TMTG has not responded. DI. 1, Ex. J at 4. UAV sent one more letter to Odyssey, asking it to confirm that all requirements have been satisfied to allow for the delivery of the shares to UAV free of any transfer restrictions if the lockup conditions are met. D.I. 1, Ex. K at 5. Odyssey responded by stating that it had no obligation to UAV until the lockup’s conditions were fully met. D.I. 1, Ex. Q. Odyssey stated that “consistent with its practice to date, Odyssey’s representatives remain willing to engage in reasonable communications with representatives of your client and/or its broker regarding the categories and forms of documents needed to effectuate future desired transfers, with a view towards honoring any valid transfer instructions that it may receive from UAV on a reasonably expeditious basis.” Jd. at 2.

Odyssey commenced litigation, seeking declaratory relief. See DI. 1. After litigation commenced, Odyssey and UAV engaged in substantive discussions that both parties agreed would have resolved the dispute. D.I. 29, Ex. A. Odyssey’s proposed stipulation provided that “[w]hen notified by TMTG of the expiration of the Lockup Provisions, Odyssey shall remove restrictions on transfer associated with the Lockup Provisions from all shares of TMTG common stock that are so subject, within a reasonably expeditious time period, without preference to any TMTG shareholder.” Jd. UAV proposed the slight addition of a notice provision. D.I. 29 45. Counsel for Odyssey accepted UAV’s proposed change with a small caveat, and the parties reached an agreement regarding the material terms that would resolve the litigation. Jd {ff 6-7. Odyssey sought approval from TMTG, and ultimately changed its position. Odyssey attempted to change “without preference to any shareholder” to “on the same basis as other similarly situated TMTG shareholders.” /d. {{ 8-9, Ex. C.

2. LEGAL STANDARD “The court shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). “A genuine issue of material fact is one that could lead a reasonable jury to find in favor of the nonmoving party.” Bletz v. Corrie, 974 F.3d 306, 308 (3d Cir. 2020) (citation omitted). “The court must review the record as a whole, draw all reasonable inferences in favor of the nonmoving party, and must not ‘weigh the evidence or make credibility determinations.’” Id. (citation omitted). The Court must enter summary judgment if the non-moving party “fails to make a showing sufficient to establish the existence of an element essential to [its] case, and on which [the non-moving] party will bear the burden of proof at trial.” Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986); see also SodexoMAGIC, LLC v. Drexel Univ., 24 F.4th 183, 204 (3d Cir. 2022) (quoting Celotex, 477 U.S. at 322).

3. DISCUSSION The parties largely do not dispute the merits of the underlying cause of action.* See D.I. 22 at 11-21. There is agreement that Odyssey owes a duty to UAV to transfer UAV its shares when requested and authorized under the law. See 6 Del. C. § 8-406; Jing Jing v. Weyland Tech, Inc., 2017 WL 2618753, at *2 (D. Del. June 15, 2017) (‘Section 8-401, which describes an issuer’s duty to register the transfer of securities, applies to the removal of a restrictive legend because a removal is deemed a registered transfer. Section 8-407 extends the issuer’s duty to

3 At oral argument, UAV agreed that if the Court were to require the shares to be transmitted without preference to any shareholder, then UAV’s request that the Court order Odyssey to listen to UAV and independently determine that the publicly available lockup conditions are met is unnecessary. 22:18-23:11 (“The Court: [A]s long as they remove the restrictions without preference to any shareholder, then what’s wrong with that? UAV’s Counsel: “We would agree to that.”).

transfer agents. Section 8-401(b) provides liability if an issuer is under a duty to register a transfer and either refuses or causes unreasonable delay.”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Abbott Laboratories v. Gardner
387 U.S. 136 (Supreme Court, 1967)
MedImmune, Inc. v. Genentech, Inc.
549 U.S. 118 (Supreme Court, 2007)
Travelers Insurance Company v. Lisa Ann Obusek
72 F.3d 1148 (Third Circuit, 1995)
Rhoades v. Avon Products, Inc.
504 F.3d 1151 (Ninth Circuit, 2007)
National Presort, Inc. v. Bowe Bell + Howell Co.
663 F. Supp. 2d 505 (N.D. Texas, 2009)
Rox-Ann Reifer v. Westport Insurance Corp
751 F.3d 129 (Third Circuit, 2014)
Ne Hub Partners, L.P. v. CNG Transmission Corp.
239 F.3d 333 (Third Circuit, 2001)
Plains All American Pipeline L v. Thomas Cook
866 F.3d 534 (Third Circuit, 2017)
Jeffrey Bletz v. Jeremy Corrie
974 F.3d 306 (Third Circuit, 2020)
California v. Texas
593 U.S. 659 (Supreme Court, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
United Atlantic Ventures, LLC v. Odyssey Transfer and Trust Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-atlantic-ventures-llc-v-odyssey-transfer-and-trust-company-ded-2024.